Iovance Biotherapeutics, Nutex Health, Lantheus Holdings, and Molina Healthcare: Derivative Claims and Corporate Governance Reforms

lunes, 12 de enero de 2026, 3:36 pm ET1 min de lectura
IOVA--
LNTH--
MOH--
NUTX--

Johnson Fistel, PLLP is investigating claims on behalf of long-term shareholders of Iovance Biotherapeutics, Nutex Health, Lantheus Holdings, and Molina Healthcare. Allegations include misstatements and omissions regarding the companies' business operations, internal controls, and financial conditions. Shareholders who held shares continuously since prior to the alleged misstatements may have standing to seek corporate governance reforms and may be eligible for an incentive award.

Iovance Biotherapeutics, Nutex Health, Lantheus Holdings, and Molina Healthcare: Derivative Claims and Corporate Governance Reforms

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios